455 related articles for article (PubMed ID: 15149624)
1. Application of statistical 'design of experiments' methods in drug discovery.
Tye H
Drug Discov Today; 2004 Jun; 9(11):485-91. PubMed ID: 15149624
[TBL] [Abstract][Full Text] [Related]
2. Process optimization using combinatorial design principles: parallel synthesis and design of experiment methods.
Gooding OW
Curr Opin Chem Biol; 2004 Jun; 8(3):297-304. PubMed ID: 15183328
[TBL] [Abstract][Full Text] [Related]
3. A review of high throughput technology for the screening of natural products.
Mishra KP; Ganju L; Sairam M; Banerjee PK; Sawhney RC
Biomed Pharmacother; 2008 Feb; 62(2):94-8. PubMed ID: 17692498
[TBL] [Abstract][Full Text] [Related]
4. From targets to leads: the importance of advanced data analysis for decision support in drug discovery.
Fischer HP; Heyse S
Curr Opin Drug Discov Devel; 2005 May; 8(3):334-46. PubMed ID: 15892249
[TBL] [Abstract][Full Text] [Related]
5. Synthetic library design.
Huwe CM
Drug Discov Today; 2006 Aug; 11(15-16):763-7. PubMed ID: 16846805
[TBL] [Abstract][Full Text] [Related]
6. Recent applications of microwave irradiation to medicinal chemistry.
Alcázar J; Oehlrich D
Future Med Chem; 2010 Feb; 2(2):169-76. PubMed ID: 21426184
[TBL] [Abstract][Full Text] [Related]
7. Framework for the rapid optimization of soluble protein expression in Escherichia coli combining microscale experiments and statistical experimental design.
Islam RS; Tisi D; Levy MS; Lye GJ
Biotechnol Prog; 2007; 23(4):785-93. PubMed ID: 17592858
[TBL] [Abstract][Full Text] [Related]
8. Screening for content--the evolution of high throughput.
Dove A
Nat Biotechnol; 2003 Aug; 21(8):859-64. PubMed ID: 12894197
[No Abstract] [Full Text] [Related]
9. When poor solubility becomes an issue: from early stage to proof of concept.
Stegemann S; Leveiller F; Franchi D; de Jong H; Lindén H
Eur J Pharm Sci; 2007 Aug; 31(5):249-61. PubMed ID: 17616376
[TBL] [Abstract][Full Text] [Related]
10. The application of micro reactors for organic synthesis.
Watts P; Haswell SJ
Chem Soc Rev; 2005 Mar; 34(3):235-46. PubMed ID: 15726160
[TBL] [Abstract][Full Text] [Related]
11. Competitive Workflow: novel software architecture for automating drug design.
Cartmell J; Krstajic D; Leahy DE
Curr Opin Drug Discov Devel; 2007 May; 10(3):347-52. PubMed ID: 17554862
[TBL] [Abstract][Full Text] [Related]
12. Chemical synthesis in microreactors.
Watts P; Haswell SJ
Methods Mol Biol; 2010; 583():109-20. PubMed ID: 19763461
[TBL] [Abstract][Full Text] [Related]
13. Automated medicinal chemistry.
Koppitz M; Eis K
Drug Discov Today; 2006 Jun; 11(11-12):561-8. PubMed ID: 16713909
[TBL] [Abstract][Full Text] [Related]
14. Image-based chemical screening.
Carpenter AE
Nat Chem Biol; 2007 Aug; 3(8):461-5. PubMed ID: 17637778
[TBL] [Abstract][Full Text] [Related]
15. Timely synthetic support for medicinal chemists.
Potoski J
Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
[TBL] [Abstract][Full Text] [Related]
16. Continuous flow microreactors for drug discovery.
Watts P
Curr Opin Drug Discov Devel; 2004 Nov; 7(6):807-12. PubMed ID: 15595441
[TBL] [Abstract][Full Text] [Related]
17. The synergy between combinatorial chemistry and high-throughput screening.
Diller DJ
Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
[TBL] [Abstract][Full Text] [Related]
18. [Bioanalytics in medicinal chemistry: from assay development to evolutive drug design].
Jose J
Ann Pharm Fr; 2009 Nov; 67(6):399-407. PubMed ID: 19900603
[TBL] [Abstract][Full Text] [Related]
19. Computational chemistry approaches to drug discovery in signal transduction.
Fischer PM
Biotechnol J; 2008 Apr; 3(4):452-70. PubMed ID: 18412174
[TBL] [Abstract][Full Text] [Related]
20. Integration of virtual and high-throughput screening.
Bajorath J
Nat Rev Drug Discov; 2002 Nov; 1(11):882-94. PubMed ID: 12415248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
